Breast Cancer
Data on Breast Cancer Reported by J. Albanell and Co-Researchers
Published in Women's Health Weekly, May 3rd, 2012
2012 MAY 3 -- "This study examined the impact of the Recurrence Score (RS) in Spanish breast cancer patients and explored the associations between clinicopathological markers and likelihood of change in treatment recommendations. Enrollment was offered consecutively to eligible women with estrogen receptor-positive; human epidermal growth factor receptor 2-negative, node-negative breast cancer," investigators in Barcelona, Spain report.
"Oncologists recorded treatment recommendation and confidence in it before and after knowing the patient's RS. Treatment recommendation changed in 32% of 107 patients enrolled: in 21% from chemohormonal (CHT) to hormonal...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
More Articles from Women's Health Weekly
- Breast Cancer
Balancing trastuzumab's survival benefits and heart risks for women with breast cancer - Cervical Cancer
Data on Cervical Cancer Published by M. Plummer and Colleagues - Menopause
Federal University Reports Research in Menopause - Ovarian Cancer
Findings from Harvard University Broaden Understanding of Ovarian Cancer - Menopause
Findings from University of Oslo in Menopause Reported - Osteoporosis
Hebrew SeniorLife researchers discover genes linked to osteoporosis, bone breaks - More from this issue of Women's Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
